ab rf proteome informatics research group iprg 2012: a study on detecting modified peptides in a...
TRANSCRIPT
A BR F
Proteome InformaticsResearch Group
iPRG 2012:
A Study on Detecting Modified Peptides in a Complex Mixture
ABRF 2012, Orlando, FL3/17-20/2012
A BR F
Proteome InformaticsResearch Group
2
IPRG2012 STUDY:DESIGN
A BR F
Proteome InformaticsResearch Group
3
Study Goals
• Primary: Evaluate the ability of participants to identify modified peptides present in a complex mixture
• Secondary: Find out why result sets might differ between participants
• Tertiary: Produce a benchmark dataset, along with an analysis resource
A BR F
Proteome InformaticsResearch Group
4
Study Design
• Use a common, rich dataset• Use a common sequence database• Allow participants to use the bioinformatic tools and
methods of their choosing• Use a common reporting template• Report results at an estimated 1% FDR (at the
spectrum level)• Ignore protein inference
A BR F
Proteome InformaticsResearch Group
5
Sample
• Tryptic digest of yeast (RM8323 – NIST), spiked with 69 synthetic modified peptides (tryptic peptides from 6 different proteins – sPRG)– Phospho (STY)– Sulfo (Y)– Mono-, di-, trimethyl (K)– Mono-, dimethyl (R)– Acetyl (K)– Nitro (Y)
A BR F
Proteome InformaticsResearch Group
6
Supplied Study Materials
• 5600 TripleTOF dataset (i.e. WIFF file)– WIFF, mzML, dta, MGF (de-isotoped);–
conversions by MS Data Converter 1.1.0– MGF (not de-isotoped – conversion by Mascot
Distiller 2.4)• 1 fasta file (UniProtKB/SwissProt S. cerevisiae,
human, + 1 bovine protein + trypsin from Dec. 2011)
• 1 template (Excel)• 1 on-line survey (Survey Monkey)
A BR F
Proteome InformaticsResearch Group
7
Instructions to Participants
1. Retrieve and analyze the data file in the format of your choosing, with the method(s) of your choosing
2. Report the peptide to spectrum matches in the provided template
3. Report measures of reliability for PTM site assignments (optional)
4. Fill out the survey
5. Attach a 1-2 page description of the methodology employed
A BR F
Proteome InformaticsResearch Group
8
iPRG 2012 STUDY:
PARTICIPATION
A BR F
Proteome InformaticsResearch Group
9
Study advertised on the ABRF website and listserv and by direct invitation from iPRG members
1. Email participation request to
2. Send official study letter with instructions
3. All further communication (e.g., questions, submission) through
iPRG membersParticipant
Questions / Answers
“Anonymizer”
Soliciting Participants and Logistics
A BR F
Proteome InformaticsResearch Group
10
Participants (i) – overall numbers
• 24 submissions– One participant submitted two result sets
• 9 initialed iPRG member submissions (with appended ‘i’)
• 2 vendor submissions (identifiable by appended ‘v’)
A BR F
Proteome InformaticsResearch Group
11
About the Participant
11
Bioinformatician/Software Developer
Mass Spectrometrist
Lab Scientist
Director/Manager
Post-Grad
ABRF MemberNonmember
I routinely analyze these sorts of dataI have worked with several data setsI have worked with a few data setsComplete Novice
A BR F
Proteome InformaticsResearch Group
12
About the Participant’s Lab
12
AcademicManufacturer/VendorBiotech/Pharma/IndustryGovernmentOther
North AmericaEuropeAsiaAustralia/NZAfrica Core Only
Software devel-opment only (no research facility)
Conduct both core functions and non-core lab research
Non-core research lab
A BR F
Proteome InformaticsResearch Group
13
Participation in sPRG Study
YESNO
•Only one participant indicated he used sPRG information to aid his analysis.
• This person was one of the least successful in identifying the spiked-in peptides!
A BR F
Proteome InformaticsResearch Group
14
Search Engine Used
14
Mascot
OMSSA
X!Tandem
Peaks/PeaksD
BpFind
SpectraST
Protein Pilo
t
Byonics
MS-GFDB
MyriMatch
Protein Pro
specto
r
Sequest
Spectrum M
ill0
1
2
3
4
5
6
7
8
9
10
A BR F
Proteome InformaticsResearch Group
15
Site Localization Software
Mascot
In-house
Peaks/PeaksD
B
OMSSApFind
Andromeda
A-Score
MyriMatch
Other
Protein Pilo
t
Protein Pro
specto
r
Proteome Disc
overer
Scaffold
Sequest
SpectraST
Spectrum M
ill0
1
2
3
4
5
6
7
8
•4 participants did not list using software for site localization.
A BR F
Proteome InformaticsResearch Group
16
Summary of Submitted Results71
755v
5828
8v
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
1000
2000
3000
4000
5000
6000
7000
# spectra Id Yes
# unique Peptides UC ID Yes
Only reported modified peptides
A BR F
Proteome InformaticsResearch Group
17
Summary of IDs and Localizations71 58
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
1000
2000
3000
4000
5000
6000
7000# No Mods# Common Mods (^q,^c,m,n,q)# Nterm Mods# AA Mutation Mods# Interesting Mods
#
Sp
ectr
a
71 58
3356
4 93
1121
1
5840
9 87 94 97 42 77
2306
8 40 87
9265
3 34
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
100
200
300
400
500
600
700# Interesting Mod Loc Certainty N# Interesting Mod Loc Certainty Y
#
Sp
ectr
a
Peptide Identificationin all Spectra
Site Localization in SpectraWith Interesting Modifications
A BR F
Proteome InformaticsResearch Group
18
Overlap of spectrum identifications
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 240
2000
4000
6000
8000
10000
12000
# Participants Agreeing
Cu
mm
ula
tive
# S
pec
tra 7840 agreed on by 3 or more participants
A BR F
Proteome InformaticsResearch Group
19
An Andromeda/MaxQuant MG MS-GFDB pF pFind Sc Scaffold
AS A-Score MM MyriMatch Pk PEAKS SM Spectrum Mill
By Byonics MO MODa PkDB PEAKSDB Sq Sequest
IH In-house software O OMSSA PPi Protein Pilot ST SpectraST
IP IDPicker Ot Other PPr Protein Prospector TPP TransProteomic Pipeline
M Mascot P/PP Pep/Prot Prophet PR PhosphoRS XL Excel
MDe Mascot Delta Score PD ProteomeDiscoverer PW ProteoWizard XT X!Tandem
MDi Mascot Distiller
7175
5v
5828
8v
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
1000
2000
3000
4000
5000
6000
7000 #ND No Id, Diff from Consensus#Y<3 P Id Yes#YD Yes Id, Diff from Consensus#NS No Id, Same as Consensus#YS Yes Id, Same as Consensus
# S
pec
tra
Room for improvement in thresholding?
71755v 58288v 33564 93128i 11211 58409 87133i 94158i 97053i 42424i 77777i 23068 40104i 87048i 92653 34284i 23117 74564 14151 52781 47603 14152 45511 11821Peaklist mgf mzML mzML mgf mgf mgf mzML mgf_nd mgf mgf_nd mgf mzML mzML mgf_nd mgf mgf mzML mgf mgf_nd mgf mgf mgf_nd mgf mgf_nd
mzML mzML mgf_nd WIFF
Spectral Pre-Processing Pk Pk PPi MDi Ot SM pF Pk MDi PDPkDB PW PkDB Sq
Peptide Identification By Pk Pk M PPi M O PPr pF M MG M P/PP SM pF M Pk M PPi M O M M PDPkDB PkDB O ST MM O TPP PkDB Sq
ST XT IH XT XTXTOt
Discovery of Unexpected Mods By Pk Pk M PPi ST PPr pF IH MO SM pF M Pk PPi O M
PkDB PkDBSite Localization Pk Pk MDe PPi M PPr pF M IH M SM pF M Pk M AS IH An MDe PD
PkDB O MM O PkDB Sc Ot SqST IH
Results Filtering By Pk Pk IH PPi P/PP P/PP PPr pF IP IH XL IH XL pF M Pk M XL Sc M PRPkDB XL Ot TPP TPP XL PkDB
NTT 2 1 1 2 1 ? 1 1 1 2 1 ? 1 2 2 2 2 ? 1 2 2 2 ? 2
Experience5-10 years
5-10 years
5-10 years
>10 years < 1 year 3-4 years
5-10 years
>10 years
5-10 years
5-10 years
5-10 years 3-4 years
5-10 years
>10 years 1-2 years
>10 years 1-2 years
>10 years
>10 years 1-2 years
>10 years
>10 years 1-2 years
>10 years
A BR F
Proteome InformaticsResearch Group
20
ESR and FDRExtraordinary Skill Rate or High False Discovery Rate? ESR + FDR = 100* (Y<3P+YD)/total ids Y 24 participants
3 for consensus
7175
5v
5828
8v
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
2
4
6
8
10
12
14
16
18
20
22
Y<3 P percent
YD percent
%
A BR F
Proteome InformaticsResearch Group
21
Characteristics of consensus spectra7840 spectra >=3 participants agreeing on sequence
Consensus requires agreement onSequence, but not modification localization
Nterm-Acetyl
Nterm-Carbamyl
Nterm-Other
PyroGlu Q
PyroGlu E
PyroCar-bamidomethylCys
m: Oxidation
n: Deamidation
q: Deamidation
c
d
e
w: Oxidation
p
k
r
s
t
y
No Variable Mods
1 10 100 1000 10000
447
3
3
70
11
6
94
310
183
6
94
107
5
3
165
45
294
137
132
6117
A BR F
Proteome InformaticsResearch Group
22
Peak lists
• Two types of peak lists were supplied– Deisotoped and non deisotoped
• Can only tell fragment charge state from non-deisotoped
• Requires search engine to be able to de-isotope spectrum
A BR F
Proteome InformaticsResearch Group
23
Peaklists
•Number of spectra with undefined precursor charge stateDeisotoped 1031 (304 in consensus results)Non-deisotoped 6094 (1140 in consensus results)
•For 1013 out of 7840 consensus spectra the precursor m/z differ by greater than 0.02 Da between deisotoped and non-deisotoped peak list.
•For 238 consensus spectra the peak lists had different specified charge state
–193 consensus results only possible with deisotoped peak list–45 consensus results only possible with non-deisotoped peak list
–For 19 consensus results multiple people who searched the nd peak list agreed on a confident different answer–For 4 consensus results multiple people who searched the deisotoped peak list agreed on a confident different answer
A BR F
Proteome InformaticsResearch Group
24
Mixed Spectra465.19 2+
464.59 3+
464.59 3+Non-deisotopedpeaklist
465.19 2+Deisotopedpeaklist
A BR F
Proteome InformaticsResearch Group
25
DEGkASSAKFkDLGEENFK
GLFIIDDkGILRLkAEGSEIR
LkLVSELWDAGIKADEGISFrGLFIIDDK
AEGSEIrLAKLDELrDEGK
GILrQITVNDLPVGRGTrDYSPR
FPkAEFAEVSKEkLLDFIK
LkAEGSEIRLkAQLGPDESK
NGDTASPkEYTAGRAEGSEIrLAK
ESTLHLVLrLRLDELrDEGK
GILrQITVNDLPVGRGTrDYSPR
EkLLDFIKFPkAEFAEVSK
LkAEGSEIRLkAQLGPDESK
NGDTASPkEYTAGREkLLDFIK
FPkAEFAEVSKLkAEGSEIR
LkAQLGPDESKNGDTASPkEYTAGR
0 5 10 15 20 25
Synthetic Peptide ID by Peptide
0 5 10 15 20 25 30
ALAPEyAKDISLSDyK
SVSDyEGKTIAQDyGVLK
TLSDyNIQKADEGIsFRAEFAEVsKDISLsDyKDISLSDyKDIsLSDyKDIsLsDyK
DQGGELLsLREStLHLVLREsTLHLVLREstLHLVLR
IFsIVEQRLVNEVtEFAK
LVQAFQFtDKNVAVDELsR
SVsDYEGKtHILLFLPKsVsDyEGKTHILLFLPKsVSDYEGK
TITLEVEPsDtIENVKtItLEVEPsDtIENVK
tLSDYNIQKtLsDYNIQK
TLSDyNIQKtLsDyNIQK
tyEtTLEKVDAtEEsDLAQQyGVR
VPQVstPtLVEVSRVPQVstPtLVEVsR
WVtFIsLLFLFssAYSRyKPEsDELtAEK
ALAPEyAKDISLSDyK
SVSDyEGKTIAQDyGVLK
TVIDyNGER
Sulfo
Phospho
Nitro
Trimethyl
Methyl (R)
Dimethyl (R)
Acetyl
Methyl (K)
Dimethyl (K)
# participants # participants
A BR F
Proteome InformaticsResearch Group
26
Synthetic Peptide ID by Participant
71755v
58288v
33564
93128i
11211
58409
87133i
94158i
97053i
42424i
77777i
23068
40104i
87048i
92653
34284i
23117
74564
14151
52781
47603
14152
45511
11821
Acetyl (K)1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Dimethyl (K)1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Dimethyl (R)1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Methyl (K)1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Methyl (R)1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Nitro (Y)1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
Phospho (STY)
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1
Sulfo (Y)1 1
1 1
1 1 1
1 1 1 1
Trimethyl (K)1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
1 1 1 1 1 1 1 1 1 1 1 1 1 1
A BR F
Proteome InformaticsResearch Group
27
Correct Localization of Modified Synthetic Peptides
70 synthetic modified peptides were spiked into sample.7 of these were confidently found by no participant
Correct localization & nameof modification reported
7175
5v
5828
8v
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
10
20
30
40
50
60
70
# Spiked Unique Peptides Correct Mod Loc, Name; Mod Loc Certainty N# Spiked Unique Peptides Correct Mod Loc, Name; Mod Loc Certainty Y
# U
niq
ue
Pep
tid
es C
orr
ect
Mo
d L
oca
liza
tio
n
A BR F
Proteome InformaticsResearch Group
28
FLR of Modified Synthetic PeptidesFLR = 100% * # PSMs wrong localization of s,t,y,k,r # PSMs wrong + right localization of s,t,y,k,r
Ignored PSMs contain mods of residues other than s,t,y,k,r . Sample handling mods (n,q,d,e, etc).
71 58
3356
4 93
1121
1
5840
9 87 94 97 42 77
2306
8 40 87
9265
3 34
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
50
100
150
200
250
300
350
400
450
500# Spiked PSMs Mod Loc Certainty N# Spiked PSMs Mod Loc Certainty Y, Ignored# Spiked PSMs Wrong Mod Loc; Mod Loc Certainty Y
# S
pik
ed
Pep
tid
e P
SM
s
71 58
3356
4
9312
8i
1121
1
5840
9
8713
3i
9415
8i
9705
3i
4242
4i
7777
7i
2306
8
4010
4i
8704
8i
9265
3
3428
4i
2311
7
7456
4
1415
1
5278
1
4760
3
1415
2
4551
1
1182
1
0
2
4
6
8
10
12
14
16
18
Sp
iked
Pep
tid
e P
SM
FL
R (
%)
5% 5% 1% 1-2% 1% <1 0.5 10% <30% 0.01 <5% <1%
A BR F
Proteome InformaticsResearch Group
29
Incorrect Localization by Peptide
71755v
58288v
33564
93128i
11211
58409
87133i
94158i
97053i
42424i
77777i
23068
40104i
87048i
92653
34284i
23117
74564
14151
52781
47603
14152
45511
11821
EKLLDFIKAEGSEIRLAK 1VDATEESDLAQQYGVRTITLEVEPSDTIENVKESTLHLVLRAEFAEVSK 1LKLVSELWDAGIKDQGGELLSLRTYETTLEK 1NGDTASPKEYTAGR 1 4 4 1 4 1LKAEGSEIRTVIDYNGER 4 3 4 4 4 4 1 1 3 3ADEGISFRYKPESDELTAEKGTRDYSPR 1VPQVSTPTLVEVSRADEGISFRGLFIIDDKALAPEYAKTIAQDYGVLK 1 1 1 1 2 1 1 1 1THILLFLPKSVSDYEGK 5 3 6 8 1 1 2 4 1WVTFISLLFLFSSAYSRIFSIVEQRTLSDYNIQK 3 1GILRQITVNDLPVGRNVAVDELSRLDELRDEGKESTLHLVLRLR 1DEGKASSAKSVSDYEGK 1 1 1 1 1 1LVQAFQFTDKLVNEVTEFAK 1GLFIIDDKGILR 1FPKAEFAEVSKLKAQLGPDESKDISLSDYK 1 1 2 3 1 3 6FKDLGEENFK
Number of PSM’s with Incorrect Site Localization – Mod Loc Confidence Y• Present as sulfo-Tyr• Present as phospho S-10 often mislocalized as S-12 or Y-14• Present as mono, di, tri methyl K often mislocalized at R
A BR F
Proteome InformaticsResearch Group
30
DISLSDY(Phospho)K
DISLSDY(Sulfo)K
Observe modified fragmentions.
Observe ‘unmodified’ fragment ions.Spectrum looks essentially identical to unmodified peptide spectrum
Phospho vs Sulfo
A BR F
Proteome InformaticsResearch Group
31
Conclusions
• Reasonable number of participants from around the globe, mainly experienced users but a few first-timers
• Large spread in number of spectra identified
• False negatives (NS) are generally much higher than false positives, so there is generally room for improvement
• Peak list was a significant factor on performance
• Varied performance in detecting PTMs
• Most participants struggled with sulfation
• Multiply phosphorylated harder to find than singly
• Most common errors in site assignment were:
• Reporting sulfo(Y) as phospho(ST)
• Mis-assignment of site/s in multiply phosphorylated peptides
A BR F
Proteome InformaticsResearch Group
32
What did the participants think?
22 out of 24 participants found the study useful
“Too many modifications at the same time. Manual validation is necessary and the right time necessary for this study is too demanding for this challenge.”
“The spiked proteins made it possible to game the study - look for the uncommon modifications only on the spikes. Of course we didn't do this. Overall I'd say this was a flawed but very interesting ABRF study.”
A BR F
Proteome InformaticsResearch Group
3333
Very ConfidentConfidentNot Confident
Very ConfidentConfidentNot ConfidentNo Experience
Before After
Participant’s Confidence in Analyzing PTM Data
A BR F
Proteome InformaticsResearch Group
34
0-8 8-16 16-24 24-32 32-40 40-48 >480
2
4
6
8
10
12
Time (hrs)
Too difficultChallengingJust right
How difficult do you think this study was?
What was your total analysis time for the entire project?
A BR F
Proteome InformaticsResearch Group
35
Based on this study, would you consider participating in future ABRF studies?
YesNo
A BR F
Proteome InformaticsResearch Group
36
Thank you! Questions?
iPRGNuno BandeiraRobert Chalkley(chair)Matt ChambersKarl ClauserJohn CottrellEric DeutschEugene KappHenry LamHayes McDonaldTom Neubert (EB liaison)Ruixiang Sun
Dataset CreationChris Colangelo
Anonymizer:Jeremy Carver, UCSD
THANK YOU TO ALLSTUDY PARTICIPANTS!